We serve Chemical Name:2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone CAS:292855-52-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone
CAS.NO:292855-52-8
Synonyms:1-(Indol-3-yl)-2-(phenylsulfonyl)ethanone
Molecular Formula:C16H13NO3S
Molecular Weight:299.34400
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:591.6ºC at 760 mmHg
Density:1.363g/cm3
Index of Refraction:1.66
PSA:75.38000
Exact Mass:299.06200
LogP:3.90530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(Indol-3-yl)-2-(phenylsulfonyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(Indol-3-yl)-2-(phenylsulfonyl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(Indol-3-yl)-2-(phenylsulfonyl)ethanone Use and application,1-(Indol-3-yl)-2-(phenylsulfonyl)ethanone technical grade,usp/ep/jp grade.
Related News: The U.S. laws governing cosmetics safety and labelling date back to 1938 and 1967, which tells you something,” Bruton said.
However, on Tuesday, Sens. Susan Collins (R-Maine) and Richard Blumenthal (D-Conn.) introduced the No PFAS in Cosmetics Act in the Senate, the Washington Post reported. The same bill was introduced in the U.S. House by Rep. Debbie Dingell (D-Michigan). It would direct the U.S. Food and Drug Administration to issue a proposed rule banning the intentional addition of PFAS in cosmetics within 270 days of the bill’s passage, and require a final rule to be issued 90 days later.
“Our bill would require the FDA to ban the addition of PFAS to cosmetics products,” Collins said in a statement. “Americans should be able to trust that the products they are applying to their hair or skin are safe. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone manufacturer The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone supplier Both patients were being treated in isolation units at a Manila hospital. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone vendor Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone factory The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.
However, on Tuesday, Sens. Susan Collins (R-Maine) and Richard Blumenthal (D-Conn.) introduced the No PFAS in Cosmetics Act in the Senate, the Washington Post reported. The same bill was introduced in the U.S. House by Rep. Debbie Dingell (D-Michigan). It would direct the U.S. Food and Drug Administration to issue a proposed rule banning the intentional addition of PFAS in cosmetics within 270 days of the bill’s passage, and require a final rule to be issued 90 days later.
“Our bill would require the FDA to ban the addition of PFAS to cosmetics products,” Collins said in a statement. “Americans should be able to trust that the products they are applying to their hair or skin are safe. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone manufacturer The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone supplier Both patients were being treated in isolation units at a Manila hospital. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone vendor Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2-(benzenesulfonyl)-1-(1H-indol-3-yl)ethanone factory The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.
